These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 803997)

  • 1. Mental decline in the elderly: pharmacotherapy (ergot alkaloids versus papaverine).
    Rosen HJ
    J Am Geriatr Soc; 1975 Apr; 23(4):169-74. PubMed ID: 803997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relieving select symptoms of the elderly.
    Nelson JJ
    Geriatrics; 1975 Mar; 30(3):133-9, 142. PubMed ID: 803912
    [No Abstract]   [Full Text] [Related]  

  • 3. Helping to make the final years meaningful for the elderly residents of nursing homes.
    Einspruch BC
    Dis Nerv Syst; 1976 Aug; 37(8):439-42. PubMed ID: 821734
    [No Abstract]   [Full Text] [Related]  

  • 4. An ergot alkaloid preparation (Hydergine) versus papaverine in treating common complaints of the aged: double-blind study.
    Bazo AJ
    J Am Geriatr Soc; 1973 Feb; 21(2):63-71. PubMed ID: 4631704
    [No Abstract]   [Full Text] [Related]  

  • 5. An ergot alkaloid preparation (Hydergine) in the treatment of dementia: critical review of the clinical literature.
    Hughes JR; Williams JG; Currier RD
    J Am Geriatr Soc; 1976 Nov; 24(11):490-7. PubMed ID: 823192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration.
    van Loveren-Huyben CM; Engelaar HF; Hermans MB; van der Bom JA; Leering C; Munnichs JM
    J Am Geriatr Soc; 1984 Aug; 32(8):584-8. PubMed ID: 6379022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical trial comparing 'Hydergine' with placebo in the treatment of cerebrovascular insufficiency in elderly patients.
    McConnachie RW
    Curr Med Res Opin; 1973; 1(8):463-8. PubMed ID: 4204090
    [No Abstract]   [Full Text] [Related]  

  • 8. [Letter: Double blind study of hydergine in aged patients].
    Paux G; Boismare F; Delaunay P
    Nouv Presse Med; 1975 Oct; 4(35):2529. PubMed ID: 812060
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydrogenated ergot alkaloids (hydergine) in the treatment of geriatric postural dizziness.
    ORMA EJ
    Ann Med Intern Fenn; 1956; 45(1):39-44. PubMed ID: 13355071
    [No Abstract]   [Full Text] [Related]  

  • 10. [Eutergine and retinal arteriosclerosis].
    Ourgaud AG; Metge P; Cazenave P
    Bull Soc Ophtalmol Fr; 1975; 75(5-6):591-607. PubMed ID: 813835
    [No Abstract]   [Full Text] [Related]  

  • 11. Dihydrogenated ergot alkaloids (Hydergine) and cerebrovascular insufficiency.
    Med Lett Drugs Ther; 1970 Mar; 12(6):27-8. PubMed ID: 4994841
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the encephalotrophic action of hydergine. Clinical study].
    Garagnani Sciarretta B; Rimondini S; Martelli A
    Minerva Med; 1974 Aug; 65(59):3090-8. PubMed ID: 4214406
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind evaluation of 'Hydergine' and placebo in the treatment of patients with organic brain syndrome and cerebral arteriosclerosis in a nursing home.
    Thibault A
    Curr Med Res Opin; 1974; 2(8):482-7. PubMed ID: 4217240
    [No Abstract]   [Full Text] [Related]  

  • 14. [Double blind test of hydergine in the aged].
    Bargheon J
    Nouv Presse Med; 1973 Sep; 2(31):2053-5. PubMed ID: 4199834
    [No Abstract]   [Full Text] [Related]  

  • 15. An ergot alkaloid preparation (hydergine) versus placebo for treatment of symptoms of cerebrovascular insufficiency: double-blind study.
    Jennings WG
    J Am Geriatr Soc; 1972 Aug; 20(8):407-12. PubMed ID: 4626496
    [No Abstract]   [Full Text] [Related]  

  • 16. Ergoloid mesylates ('Hydergine') in the treatment of mental deterioration in the elderly: a 6-month double-blind, placebo-controlled trial.
    Rouy JM; Douillon AM; Compan B; Wolmark Y
    Curr Med Res Opin; 1989; 11(6):380-9. PubMed ID: 2651014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydergine for dementia.
    Olin J; Schneider L; Novit A; Luczak S
    Cochrane Database Syst Rev; 2001; (2):CD000359. PubMed ID: 11405961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ergot preparation (hydergine) in the treatment of cerebrovascular disorders in the geriatric patient: double-blind study.
    Ditch M; Kelly FJ; Resnick O
    J Am Geriatr Soc; 1971 Mar; 19(3):208-17. PubMed ID: 4998602
    [No Abstract]   [Full Text] [Related]  

  • 19. Overview of clinical trials of hydergine in dementia.
    Schneider LS; Olin JT
    Arch Neurol; 1994 Aug; 51(8):787-98. PubMed ID: 8042927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy of acute cerebral ischemia. Clinical study].
    Almici C; Lazzaroni G
    G Clin Med; 1974 Dec; 55(12):880-9. PubMed ID: 4219970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.